[Prognosis scores to help revascularization for ischemic heart failure]

Area of Science:

• Cardiology
• Interventional Cardiology
• Cardiac Surgery

Context:

• Patients with coronary heart disease and ventricular systolic dysfunction have a poor prognosis.
• Revascularization is crucial for improving outcomes in these patients.
• Surgical revascularization has traditionally been the primary approach.

Purpose:

• To compare the clinical outcomes of surgical revascularization, angioplasty, and medical treatment.
• To develop a prognostic score to guide therapy selection for patients with ischemic heart failure.
• To identify significant predictors of mortality and major adverse cardiac events (MACE).

Summary:

• A cohort study of 492 patients (1995-2000) compared surgery, angioplasty, and medical treatment.
• No significant difference in mortality was observed between groups after a mean 32-month follow-up.
• Survival without MACE was highest in the surgical group, intermediate in the angioplasty group, and lowest in the medical group.
• A prognostic score was developed to stratify patients by severity, indicating surgery's superiority for intermediate-risk patients.

Impact:

• The developed prognostic score aids physicians in selecting the most appropriate revascularization technique.
• This tool can personalize treatment strategies for patients with severe ischemic heart failure.
• Optimizing revascularization choice may lead to improved event-free survival rates.